Cargando…

Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention

BACKGROUND: Cholangiocarcinoma is a disease with a high mortality rate. Our previous study revealed that cholelithiasis patients who undergo endoscopic sphincterotomy (ES)/endoscopic papillary balloon dilatation are at a higher risk for subsequent cholangiocarcinoma than cholelithiasis patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chi-Chih, Tseng, Ming-Hseng, Wu, Sheng-Wen, Yang, Tzu-Wei, Chen, Hsuan-Yi, Sung, Wen-Wei, Su, Chang-Cheng, Wang, Yao-Tung, Lin, Chun-Che, Tsai, Ming-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739153/
https://www.ncbi.nlm.nih.gov/pubmed/33362909
http://dx.doi.org/10.4251/wjgo.v12.i12.1381
_version_ 1783623272512880640
author Wang, Chi-Chih
Tseng, Ming-Hseng
Wu, Sheng-Wen
Yang, Tzu-Wei
Chen, Hsuan-Yi
Sung, Wen-Wei
Su, Chang-Cheng
Wang, Yao-Tung
Lin, Chun-Che
Tsai, Ming-Chang
author_facet Wang, Chi-Chih
Tseng, Ming-Hseng
Wu, Sheng-Wen
Yang, Tzu-Wei
Chen, Hsuan-Yi
Sung, Wen-Wei
Su, Chang-Cheng
Wang, Yao-Tung
Lin, Chun-Che
Tsai, Ming-Chang
author_sort Wang, Chi-Chih
collection PubMed
description BACKGROUND: Cholangiocarcinoma is a disease with a high mortality rate. Our previous study revealed that cholelithiasis patients who undergo endoscopic sphincterotomy (ES)/endoscopic papillary balloon dilatation are at a higher risk for subsequent cholangiocarcinoma than cholelithiasis patients who undergo cholecystectomy. AIM: To clarify the relationship between recurrent biliary events and subsequent cholangiocarcinoma risk in choledocholithiasis patients. METHODS: From one million random cases in the Taiwan National Health Insurance Research Database 2004–2011, we selected symptomatic choledocholithiasis patients older than 18 years who were admitted from January 2005 to December 2009 (study group). Cases for a control group were defined as individuals who had never been diagnosed with cholelithiasis, matched by sex and age in a 1:3 ratio. The study group was further divided into ES/endoscopic papillary balloon dilatation, both ES/endoscopic papillary balloon dilatation and cholecystectomy, and no intervention groups. RESULTS: We included 2096 choledocholithiasis patients without previous intervention or cholangiocarcinoma. A total of 12 (2.35%), 11 (0.74%), and 1 (1.00%) subsequent cholangiocarcinoma cases were diagnosed among 511 ES/endoscopic papillary balloon dilatation patients, 1485 patients with no intervention, and 100 ES/endoscopic papillary balloon dilatation and cholecystectomy patients, respectively. The incidence rates of recurrent biliary event were 527.79/1000 person-years and 286.69/1000 person-years in the subsequent cholangiocarcinoma and no cholangiocarcinoma group, showing a high correlation between subsequent cholangiocarcinoma risk and recurrent biliary events. CONCLUSION: Choledocholithiasis patients who undergo further cholecystectomy after ES/endoscopic papillary balloon dilatation have decreased subsequent cholangiocarcinoma risk due to reduced recurrent biliary events.
format Online
Article
Text
id pubmed-7739153
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-77391532020-12-24 Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention Wang, Chi-Chih Tseng, Ming-Hseng Wu, Sheng-Wen Yang, Tzu-Wei Chen, Hsuan-Yi Sung, Wen-Wei Su, Chang-Cheng Wang, Yao-Tung Lin, Chun-Che Tsai, Ming-Chang World J Gastrointest Oncol Retrospective Cohort Study BACKGROUND: Cholangiocarcinoma is a disease with a high mortality rate. Our previous study revealed that cholelithiasis patients who undergo endoscopic sphincterotomy (ES)/endoscopic papillary balloon dilatation are at a higher risk for subsequent cholangiocarcinoma than cholelithiasis patients who undergo cholecystectomy. AIM: To clarify the relationship between recurrent biliary events and subsequent cholangiocarcinoma risk in choledocholithiasis patients. METHODS: From one million random cases in the Taiwan National Health Insurance Research Database 2004–2011, we selected symptomatic choledocholithiasis patients older than 18 years who were admitted from January 2005 to December 2009 (study group). Cases for a control group were defined as individuals who had never been diagnosed with cholelithiasis, matched by sex and age in a 1:3 ratio. The study group was further divided into ES/endoscopic papillary balloon dilatation, both ES/endoscopic papillary balloon dilatation and cholecystectomy, and no intervention groups. RESULTS: We included 2096 choledocholithiasis patients without previous intervention or cholangiocarcinoma. A total of 12 (2.35%), 11 (0.74%), and 1 (1.00%) subsequent cholangiocarcinoma cases were diagnosed among 511 ES/endoscopic papillary balloon dilatation patients, 1485 patients with no intervention, and 100 ES/endoscopic papillary balloon dilatation and cholecystectomy patients, respectively. The incidence rates of recurrent biliary event were 527.79/1000 person-years and 286.69/1000 person-years in the subsequent cholangiocarcinoma and no cholangiocarcinoma group, showing a high correlation between subsequent cholangiocarcinoma risk and recurrent biliary events. CONCLUSION: Choledocholithiasis patients who undergo further cholecystectomy after ES/endoscopic papillary balloon dilatation have decreased subsequent cholangiocarcinoma risk due to reduced recurrent biliary events. Baishideng Publishing Group Inc 2020-12-15 2020-12-15 /pmc/articles/PMC7739153/ /pubmed/33362909 http://dx.doi.org/10.4251/wjgo.v12.i12.1381 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Retrospective Cohort Study
Wang, Chi-Chih
Tseng, Ming-Hseng
Wu, Sheng-Wen
Yang, Tzu-Wei
Chen, Hsuan-Yi
Sung, Wen-Wei
Su, Chang-Cheng
Wang, Yao-Tung
Lin, Chun-Che
Tsai, Ming-Chang
Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention
title Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention
title_full Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention
title_fullStr Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention
title_full_unstemmed Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention
title_short Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention
title_sort cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention
topic Retrospective Cohort Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739153/
https://www.ncbi.nlm.nih.gov/pubmed/33362909
http://dx.doi.org/10.4251/wjgo.v12.i12.1381
work_keys_str_mv AT wangchichih cholecystectomyreducessubsequentcholangiocarcinomariskincholedocholithiasispatientsundergoingendoscopicintervention
AT tsengminghseng cholecystectomyreducessubsequentcholangiocarcinomariskincholedocholithiasispatientsundergoingendoscopicintervention
AT wushengwen cholecystectomyreducessubsequentcholangiocarcinomariskincholedocholithiasispatientsundergoingendoscopicintervention
AT yangtzuwei cholecystectomyreducessubsequentcholangiocarcinomariskincholedocholithiasispatientsundergoingendoscopicintervention
AT chenhsuanyi cholecystectomyreducessubsequentcholangiocarcinomariskincholedocholithiasispatientsundergoingendoscopicintervention
AT sungwenwei cholecystectomyreducessubsequentcholangiocarcinomariskincholedocholithiasispatientsundergoingendoscopicintervention
AT suchangcheng cholecystectomyreducessubsequentcholangiocarcinomariskincholedocholithiasispatientsundergoingendoscopicintervention
AT wangyaotung cholecystectomyreducessubsequentcholangiocarcinomariskincholedocholithiasispatientsundergoingendoscopicintervention
AT linchunche cholecystectomyreducessubsequentcholangiocarcinomariskincholedocholithiasispatientsundergoingendoscopicintervention
AT tsaimingchang cholecystectomyreducessubsequentcholangiocarcinomariskincholedocholithiasispatientsundergoingendoscopicintervention